Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Anderson

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|April 25, 1988
Reversible dissociation of active octamer of cyanase to inactive dimer promoted by alteration of the sulfhydryl groupP M Anderson, W V Johnson, J J Korte, et al.
Cancer Research|March 15, 1990
Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastasesP M Anderson, E Katsanis, A S Leonard, et al.
The Journal of Experimental Biology|June 29, 2002
Glutamine synthetase expression in liver, muscle, stomach and intestine of Bostrichthys sinensis in response to exposure to a high exogenous ammonia concentrationP M Anderson, M A Broderius, K C Fong, et al.
The Journal of Pharmacy and Pharmacology|November 19, 1997
Nebulized interleukin 2 liposomes: aerosol characteristics and biodistributionC Khanna, J C Waldrep, P M Anderson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysisE Katsanis, M A Bausero, A C Ochoa, et al.
Bone Marrow Transplantation|August 29, 1998
Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantationP M Anderson, N K Ramsay, X O Shu, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agentD A Saltzman, C P Heise, D E Hasz, et al.
Bone Marrow Transplantation|October 1, 1994
Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activityE Katsanis, Z Xu, P M Anderson, et al.
Journal of Bacteriology|March 1, 1993
A physiological role for cyanate-induced carbonic anhydrase in Escherichia coliM B Guilloton, A F Lamblin, E I Kozliak, et al.
Cancer Research|November 1, 1996
A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptakeP Hu, J L Hornick, M S Glasky, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|April 25, 1988
Reversible dissociation of active octamer of cyanase to inactive dimer promoted by alteration of the sulfhydryl groupP M Anderson, W V Johnson, J J Korte, et al.
Cancer Research|March 15, 1990
Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastasesP M Anderson, E Katsanis, A S Leonard, et al.
The Journal of Experimental Biology|June 29, 2002
Glutamine synthetase expression in liver, muscle, stomach and intestine of Bostrichthys sinensis in response to exposure to a high exogenous ammonia concentrationP M Anderson, M A Broderius, K C Fong, et al.
The Journal of Pharmacy and Pharmacology|November 19, 1997
Nebulized interleukin 2 liposomes: aerosol characteristics and biodistributionC Khanna, J C Waldrep, P M Anderson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysisE Katsanis, M A Bausero, A C Ochoa, et al.
Bone Marrow Transplantation|August 29, 1998
Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantationP M Anderson, N K Ramsay, X O Shu, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agentD A Saltzman, C P Heise, D E Hasz, et al.
Bone Marrow Transplantation|October 1, 1994
Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activityE Katsanis, Z Xu, P M Anderson, et al.
Journal of Bacteriology|March 1, 1993
A physiological role for cyanate-induced carbonic anhydrase in Escherichia coliM B Guilloton, A F Lamblin, E I Kozliak, et al.
Cancer Research|November 1, 1996
A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptakeP Hu, J L Hornick, M S Glasky, et al.
Pageof 12